MLH1 and glioblastoma: We see little change in the gene expression of MLH1 and MLH2, however, previously, we have reported that indeed, hypoxia causes low-level resistance to cisplatin in GBM cells (Cowman et al., 2019), which could be due to PMS2 downregulation.